Shionogi completed the acquisition of Sumitomo Corporation’s 29% stake in C&O in December 2019. Upon completion of the acquisition, Shionogi became the sole shareholder with shareholding of 100% held in C&O.
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account 
Mobile page